Supplements vergleichen

Prescription-only, clinician-titrated. Subcutaneous injection immediately before major meals. Type 1 diabetes: typically start 15 µg and titrate to 30-60 µg per meal. Type 2 diabetes (on mealtime insulin): typically start 60 µg and titrate to 120 µg per meal. Reduce mealtime insulin (often by ~50%) when starting. DO NOT self-dose.

With meals · with food

Subkutane präprandiale Injektion (Symlin / SymlinPen)

Prescription-only, clinician-titrated. Subcutaneous (Wegovy weight management: escalate to 2.4 mg once weekly; Ozempic diabetes: 0.5-2.0 mg once weekly). Oral (Rybelsus diabetes: 3-14 mg once daily). DO NOT self-dose.

Any time

Subkutane einmal wöchentliche Injektion (Ozempic / Wegovy)

• Confirmed diagnosis of gastroparesis (slowed gastric emptying would be worsened)
• Hypoglycemia unawareness
• Poor compliance with current insulin regimen or self-monitoring of blood glucose

• Insulin (mealtime / prandial)
• Other glucose-lowering agents (sulfonylureas, etc.)
• Oral medications requiring rapid absorption

• Personal or family history of medullary thyroid carcinoma (MTC)
• Multiple Endocrine Neoplasia syndrome type 2 (MEN2)
• Prior serious hypersensitivity to semaglutide or any GLP-1 receptor agonist

• Insulin and sulfonylureas
• Oral medications (general)
• Other GLP-1 receptor agonists